Advisor Group Holdings, Inc. Cytokinetics Inc Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,018 shares of CYTK stock, worth $139,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,018

Previous 5,489 45.02%

Holding current value

$139,310

Previous $289,000 51.21%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$46.36 - $58.62 $114,555 - $144,850	-2,471 Reduced 45.02%	3,018 $141,000
Q3 2024 Nov 13, 2024	BUY	$51.22 - $60.16 $152,328 - $178,915	2,974 Added 118.25%	5,489 $289,000
Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $12,826 - $20,113	-268 Reduced 9.63%	2,515 $136,000
Q1 2024 May 10, 2024	SELL	$63.75 - $108.06 $240,720 - $408,034	-3,776 Reduced 57.57%	2,783 $195,000
Q4 2023 Feb 12, 2024	SELL	$26.88 - $83.49 $10,106 - $31,392	-376 Reduced 5.42%	6,559 $547,000
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $43,424 - $53,963	1,474 Added 26.99%	6,935 $204,000
Q2 2023 Aug 10, 2023	BUY	$32.62 - $40.75 $8,937 - $11,165	274 Added 5.28%	5,461 $178,000
Q1 2023 May 12, 2023	SELL	$33.36 - $45.71 $3,302 - $4,525	-99 Reduced 1.87%	5,187 $182,000
Q4 2022 Feb 10, 2023	SELL	$35.77 - $51.11 $155,492 - $222,175	-4,347 Reduced 45.13%	5,286 $242,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $599,412 - $847,949	-15,553 Reduced 61.75%	9,633 $467,000
Q2 2022 Aug 10, 2022	BUY	$33.93 - $48.92 $653,356 - $942,003	19,256 Added 324.72%	25,186 $992,000
Q1 2022 May 04, 2022	BUY	$29.74 - $46.0 $51,926 - $80,316	1,746 Added 41.73%	5,930 $154,000
Q3 2021 Nov 05, 2021	BUY	$18.54 - $35.74 $1,612 - $3,109	87 Added 2.12%	4,184 $151,000
Q2 2021 Aug 02, 2021	BUY	$19.79 - $26.99 $3,878 - $5,290	196 Added 5.02%	4,097 $83,000
Q1 2021 May 13, 2021	BUY	$18.57 - $25.68 $21,838 - $30,199	1,176 Added 43.16%	3,901 $92,000
Q4 2020 Feb 10, 2021	BUY	$15.26 - $28.61 $20,478 - $38,394	1,342 Added 97.04%	2,725 $55,000
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $1,181 - $2,611	-106 Reduced 7.12%	1,383 $33,000
Q1 2020 May 18, 2020	BUY	$8.75 - $16.3 $13,028 - $24,270	1,489 New	1,489 $18,000

Others Institutions Holding CYTK

# of Institutions

404

Shares Held

126M

Call Options Held

3.24M

Put Options Held

2.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Cytokinetics Inc Transaction History